Related Experiment Video
Updated: Jul 17, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Pediatric liver disease
1Department of Child Health, Guy's, King's, and St. Thomas' School of Medicine, King's College Hospital, London, United Kingdom.
Insights
Children with chronic liver disease will transition to adult care, necessitating ongoing outcome data review for optimized treatment. Pediatric hepatology requires collaboration between pediatric and adult specialists for seamless patient care transitions.
Area of Science:
- Pediatric Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Pediatric hepatology aims to cure or mitigate liver disease in children.
- Effective management requires a long-term perspective, anticipating lifelong conditions.
- Successful outcomes depend on the transition of care from pediatric to adult specialists.
Purpose of the Study:
- To highlight the evolving landscape of pediatric liver disease management.
- To emphasize the need for continuous outcome data evaluation.
- To underscore the importance of interdisciplinary collaboration between pediatric and adult medical professionals.
Main Methods:
- This is a conceptual review and discussion paper.
- It synthesizes current understanding of pediatric liver disease progression.
- It emphasizes the need for data-driven treatment optimization.
Main Results:
- Children with chronic liver disease will become adults with chronic liver disease.
- Long-term follow-up will increasingly involve adult care physicians.
- Continuous outcome data reappraisal is crucial for treatment optimization.
Conclusions:
- Pediatric hepatology requires a lifelong care approach.
- Transitioning care requires collaboration and data sharing between pediatric and adult specialists.
- Optimizing treatment necessitates ongoing monitoring and adaptation of care strategies.
Abstract:
Pediatric hepatology is no different than any other pediatric specialty. The prime objective is either to cure disease or to minimize its impact on the child. The result will be that children with chronic liver disease will become adults with chronic liver disease, and the long-term follow-up of pediatric liver disease will pass out of the hands of pediatricians. For this to happen effectively, continuous reappraisal of outcome data will be required to optimize treatment at all stages. It will also become important for physicians in adult practice to follow the progress being made in the management of pediatric liver disease.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

